Cargando…
Cost-Effectiveness of Asenapine in the Treatment of Patients with Bipolar I Disorder with Mixed Episodes in an Italian Context
INTRODUCTION: Bipolar disorder is a chronic disease characterized by periods of mania or hypomania, depression, or a combination of both (mixed state). Because bipolar disorder is one of the leading causes of disability, it represents an important economic burden on society. Asenapine (ASE) is a new...
Autores principales: | Caresano, Chiara, Di Sciascio, Guido, Fagiolini, Andrea, Maina, Giuseppe, Perugi, Giulio, Ripellino, Claudio, Vampini, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147242/ https://www.ncbi.nlm.nih.gov/pubmed/25055791 http://dx.doi.org/10.1007/s12325-014-0139-3 |
Ejemplares similares
-
C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants used in major depressive disorder in the regional Italian settings of Veneto and Sardinia
por: Mencacci, Claudio, et al.
Publicado: (2013) -
Asenapine for bipolar disorder
por: Scheidemantel, Thomas, et al.
Publicado: (2015) -
Cost-effectiveness of asenapine in the treatment of bipolar disorder in Canada
por: Lachaine, Jean, et al.
Publicado: (2014) -
Effects of asenapine on agitation and hostility in adults with acute manic or mixed episodes associated with bipolar I disorder
por: Citrome, Leslie, et al.
Publicado: (2017) -
The role of asenapine in the treatment of manic or mixed states associated with bipolar I disorder
por: Pompili, Maurizio, et al.
Publicado: (2011)